| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |